Genscript Biotech Corporation
1548Biotechnology
HK$37.70+2.72%As of Oct 29vs prior close
- Market cap
- $11B
- P/E (TTM)
- –
- P/E (FY1)
- 160.2×
- From 52W high
- −23.28%
- EPS (TTM)
- –
- Revenue (LTM)
- $845M
- Net margin
- -75.35%
Nomior Score
62
Steady ProfileTop 23% of the scored universe
Growth54
Quality57
Value50
Momentum89
Resilience38
Growth
+15.32%revenue a year over 3 fiscal years
YE22 $625.7MLTM $845M
Connections
Revenue to profitYE25
The net loss was 56% of revenue, wider by 554 pts on a year.